GSK plc Files Director Shareholding Notice
Ticker: GLAXF · Form: 6-K · Filed: Sep 22, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Sep 22, 2025 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $40.7387 |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, director-disclosure, 6-K
TL;DR
GSK director Wendy Becker filed a shareholding notice, check the 6-K for details.
AI Summary
On September 22, 2025, GSK plc filed a Form 6-K to report a transaction notification from Wendy Becker, an Independent Non-Executive Director. The filing details shareholding information related to this director.
Why It Matters
This filing provides transparency into the holdings of key personnel within GSK plc, which can be of interest to investors monitoring insider activity.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of director shareholding information, not indicating any significant operational or financial changes.
Key Players & Entities
- GSK plc (company) — Registrant
- Wendy Becker (person) — Independent Non-Executive Director
- 001-15170 (dollar_amount) — Commission File Number
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Who is the subject of the transaction notification?
The transaction notification is regarding Wendy Becker, an Independent Non-Executive Director of GSK plc.
What is the company's principal executive office address?
The company's principal executive office is located at 79 New Oxford Street, London, WC1A 1DG.
Does GSK plc file annual reports under Form 20-F?
Yes, the filing indicates that GSK plc files annual reports under cover of Form 20-F.
What is the SIC code for GSK plc?
The Standard Industrial Classification (SIC) code for GSK plc is 2834, Pharmaceutical Preparations.
Filing Stats: 1,446 words · 6 min read · ~5 pages · Grade level 17.8 · Accepted 2025-09-22 12:17:36
Key Financial Figures
- $40.7387 — rice(s) Volume(s)     $40.7387   240   d) Aggregat
Filing Documents
- a2998a.htm (6-K) — 160KB
- 0001654954-25-010981.txt ( ) — 161KB
SIGNATURES
SIGNATURES     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.   GSK plc   (Registrant)     Date: September 22, 2025         By:/s/ VICTORIA WHYTE --------------------------       Victoria Whyte   Authorised Signatory for and on   behalf of GSK plc